# clm_48045D19FF6B

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 221,700,000 United States dollar  
valid_from: 2013-09-30  
valid_to: 2014-03-31  
published: 2013-11-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_70C273FE1AD2  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 221,700,000 United States dollar", as of 2013-09-30 (until 2014-03-31). Claim clm_48045D19FF6B, https://asof.is/claim/clm_48045D19FF6B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532013000045/0000875320-13-000045-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q3 FY2013, filed 2013-11-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532013000045/0000875320-13-000045-index.htm (primary, SEC EDGAR 10-Q Q3 FY2013, published 2013-11-07)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 310,750,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_48045D19FF6B](/claim/clm_48045D19FF6B.md) | [clm_FF8C09587BDA](/claim/clm_FF8C09587BDA.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.